Skip to content

Canopy News

Articles

ASCO
Clinical

Canopy Publishes Research at 2023 American Society of Clinical Oncology Meeting

21-Month Study Demonstrates the Impact of ePROs in Identifying Patients at Risk of Early Treatment Discontinuation New York, New York - Canopy, the first Intelligent Care Platform for oncology, today announced results from a 21-month, real-world study demonstrating that electronic patient-reported outcomes (ePROs) can help identify common side effects in lung cancer patients receiving immunotherapy, both as monotherapy and in combination with chemotherapy. The Identification of key symptomatic differences in patients with shorter duration of therapy could suggest that aggressive early management can extend time on therapy, leading to improved outcomes.

Read more
Nurse
Operational

Webinar Recap: Maximizing Time and Resources

Cancer & Hematology Centers Partner with Canopy to Improve Clinical Workflows for Enhanced Patient Care Oncology practices today need comprehensive technology solutions that are versatile in their appeal and agile enough to handle unique needs across different departments.

Chantel Hopper
Read more

Media Coverage